CELLINK, a leading 3D bioprinter provider, announced the launch of BIO X6, a six-printhead bioprinting platform that enables users to combine more materials, cells and tools than any other system on ...

Cellink’s BIO X6, a six-printhead bioprinting platform, offers the capability to combine more materials, cells, and tools to enhance research applications across the bioprinting field. BIO X6, a ...

STOCKHOLM, March 15, 2021 /PRNewswire/ -- CELLINK has announced the launch of the BIO MDX™ Series, the next generation of bioprinters designed for high-throughput biofabrication and precision 3D ...

CELLINK has this week unveiled a new addition to their range of Bioprinters with the launch of the new BIO X printer which provides tissue engineers with both Pneumatic and syringe extrusion ...

CELLINK has been granted a patent for a unique cellulose-based bioink technology enabling bioprinting of multiple cell types for cell culturing, tissue engineering and regenerative medicine ...

CELLINK has launched the next part of a multiphase bioink expansion. This phase includes the release of two new bioink series, the expansion of three existing bioink series, the release of a new ...

Collplant Biotechnologies Ltd. has signed a collaboration agreement with 3D bioprinting company Cellink AB for future commercial production of regenerative breast implants. Rehovot, Israel-based ...